CTS08 - COVID-19 Vaccines

Speaker(s)

• LB

  Lindsey Baden, MD

  Attending Physician
  Brigham and Women's Hospital
  Boston, MA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MC

  Myron Cohen, MD

  Associate Vice Chancellor for Global Health
  Department of Medicine, Division of Infectious Disease
  University of North Carolina
  Chapel Hill, NC

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Ann Falsey, MD

  Professor of Medicine
  University of Rochester, School of Medicine
  Rochester, New York

  Disclosure: Janssen : Advisor or Review Panel member (Status: Ongoing), Grant/Research Support (Status: Ongoing); Merck, Sharpe and Dohme : Grant/Research Support (Status: Ongoing); Novavax : DSMB (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Pfizer : Advisor or Review Panel member (Status: Ongoing), Grant/Research Support (Status: Ongoing)
• 

  Karen Kotloff, MD

  Professor, Division Head
  Pediatric Infectious Diseases And Tropical Medicine
  University of Maryland School of Medicine
  Baltimore, MD

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MM

  Mary Marovich

  National Institutes of Health

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Learning Objectives:

• list the current vaccines under development for COVID-19
• discuss the current status of the various vaccines under development to prevent COVID-19

Presentations:

• 5:30pm – 5:45pm EDT

  Vaccine Trials Overview
  Mary Marovich – National Institutes of Health
• 5:45pm – 5:55pm EDT

  mRNA Vaccines
  Lindsey R. Baden, MD – Brigham and Women's Hospital
• 5:55pm – 6:05pm EDT

  Vectored COVID Vaccines
  Ann Falsey, MD – University of Rochester, School of Medicine
• 6:05pm – 6:15pm EDT

  Protein/adjuvant Vaccines
  Karen L. Kotloff, MD – University of Maryland School of Medicine
• 6:15pm – 6:25pm EDT

  Monoclonal Antibodies for Prevention and Treatment of COVID-19
  Myron Cohen, MD – University of North Carolina